Functional studies on native human dendritic cells (DCs) are hampered by technical difficulties in preparing fresh DCs. Recently, with the help of the monoclonal antibody M-DC8, we succeeded in isolating a major subpopulation of human blood DCs by a one-step immunomagnetic separation procedure. These cells strongly express FcγRIII (CD16) and FcγRII (CD32) and are quite efficient in the antigen specific activation of naive T cells. Because some Fcγ receptor-bearing cell types are known as effector cells in antibody-dependent cellular cytotoxicity (ADCC), we investigated whether M-DC8+ DCs are capable of effectuating ADCC. In this report we show that freshly prepared M-DC8+ DCs efficiently mediate tumor directed ADCC and that both types of Fcγ receptors as well as tumor necrosis factor α essentially contribute to the cytotoxic activity. The results provide evidence that, in addition to their pivotal role in primary T-cell activation, a subset of blood DCs displays efficient cytotoxicity in ADCC. © 2002 by The American Society of Hematology.
CITATION STYLE
Schmitz, M., Zhao, S., Schäkel, K., Bornhäuser, M., Ockert, D., & Rieber, E. P. (2002). Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity. Blood, 100(4), 1502–1504. https://doi.org/10.1182/blood.v100.4.1502.h81602001502_1502_1504
Mendeley helps you to discover research relevant for your work.